Logmore, a Finnish provider of supply chain analytics solutions, announced on Wednesday the launch of a new logistics monitor designed for COVID-19 vaccine delivery.
Logmore Dry Ice, a high-spec version of the company's original data recorder, has been adapted for cold and sub-zero conditions. It is designed for sensitive shipments such as COVID-19 vaccines which require deep freeze storage of as low as -80ºC throughout their journey.
The logger has an additional sensor connected to it with a cable. By placing only the external sensor inside the box, the device can monitor internal temperatures despite remaining outside the box -- allowing it to handle far lower temperatures than comparable products.
The device's ability to monitor temperature, humidity, shocks, tilt and light in real-time will help ensure that life-saving vaccines can be distributed in optimum condition, Logmore said.
Pfizer and BioNTech granted FDA approval for XFG-adapted COVID-19 vaccine
4basebio announces strategic collaboration with Genezen
Charles River and Medigen collaborate on next-generation enterovirus vaccine development
Innorna Nominated for 2026 Prix Galien USA Best Startup Award
Sanofi's MenQuadfi receives EU approval for infants from six weeks
Evaxion to present three-year cancer vaccine data at ESMO Congress 2026
Evaxion presents new preclinical data on cytomegalovirus vaccine EVX-V1
Northwest Biotherapeutics presents on propensity score matching at BNOS 2026
Taiwan biomedical startups hold over 100 business meetings at BIO 2026
SK bioscience to lead Gates Foundation-funded ROTOR project
Anixa Biosciences' breast cancer vaccine technology granted first Korean patent
Transgene expands myvac platform into non-small cell lung cancer with TG4070
Replicate Bioscience awarded Gates Foundation grant to advance srRNA vaccine candidates for TB